Search

Search Constraints

You searched for: Author/Creator Wallace, Daniel J

Search Results

2. 102 M-Phase Phosphoprotein 1 (MPP-1) Autoantibodies as a Potential Biomarker for Cranial Neuropathies in an International SLE Inception Cohort. (14th December 2022)

3. 199 Baricitinib in patients with systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study. (April 2019)

4. 2001 α-ketoglutarate-dependent KDM6 histone demethylases epigenetically regulate Interferon Stimulated Gene expression in Lupus. (14th December 2022)

5. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Issue 9 (2nd September 2019)

6. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Issue 9 (5th August 2019)

7. 237 Cell bound complement activation products in combination with low complement C3 or C4 have high diagnostic yield in systemic lupus erythematosus. (April 2019)

8. 603 Remission and low disease activity are associated with lower health care costs in an international inception cohort of patients with systemic lupus erythematosus. (14th December 2022)

9. A plausibly causal functional lupus-associated risk variant in the STAT1–STAT4 locus. (18th April 2018)

10. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Issue 9 (19th June 2019)